Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record now shows 'Active, not recruiting' instead of 'Recruiting' and adds new sections for Study Status, Recruitment Status, and Contacts/Locations. The page also includes a new last update date (2026-05-11) and revision (v3.5.4).
    Difference
    0.9%
    Check dated 2026-05-16T09:36:18.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating an internal site release without changing the study history details shown.
    Difference
    0.1%
    Check dated 2026-04-25T06:13:22.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the history; Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-18T03:55:00.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:20.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the record history. Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:15.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the Record History; removed the funding-status notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T14:23:22.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.